not just those that test drugs or devices. Image by Esther Dyson.
The movement to make data from clinical trials widely accessible has achieved enormous success, and it is now time for medical journals to play their part. From 1 July The BMJ will extend its requirements for data sharing to apply to all submitted clinical trials, not just those that test drugs or devices.
The BMJ’s Elizabeth Loder explains what this means for authors, and how we expect researchers to make their data available.
Press Play > to listen to the recording.
Sources and more information
- The BMJ requires data sharing on request for all trials,
BMJ 2015;350:h2373, 07 May 2015.
Reblogged this on Chaos Theory and Pharmacology and commented:
Additional information:
1. Should scientists share their data? Yes
http://chaoticpharmacology.com/2015/03/16/question-should-scientists-share-their-data-a-yes-b-no-via-epmonthly-figshare/
2. Open data manifesto
http://chaoticpharmacology.com/2014/12/13/denton-declaration-an-open-data-manifesto/
many thanks Jorge
I am convinced that scientist must share their data of clinical studies. Thank you too, for sharing information about this problem, as well as other related topics. Cheers.
😀